Linking spurious drugs with legitimate manufacturers has severe reputational, financial impact: IPA

The Indian Pharmaceutical Alliance (IPA) has called for a clear distinction between spurious and sub-standard drugs following a CDSCO report listing over 50 products as 'not of standard quality'. Major drug firms like Sun Pharma and Glenmark assert that flagged medicines are counterfeits, not their products. IPA emphasizes the need to protect India's reputation as a reliable medicine supplier.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/AB0WwEI
via IFTTT